Management of Menstrual Migraine

Purpose of ReviewMigraine disease is a neurological brain disorder that has been associated with significant disability and socioeconomic burden affecting women three times more commonly than men. Menstrual migraine is a subclass of migraine disease affecting 42–61% of females living with migraine disease. Menstrual migraine is often far more disabling, of longer duration, and more resistant to treatment. It is crucial to gain a deeper understanding of the ongoing biological changes and have a current awareness of the management of this debilitating form of migraine disease to improve the quality of life of these females living with migraine disease.Recent FindingsIn new treatment options such as devices and with large-scale genome-wide association studies in migraine, genes related to migraine are being identified.SummaryThis article will review the current literature regarding the pathophysiology, epidemiology, and treatment of menstrual migraine.